Search for the latest oncology news by tumour type
Study finds melanoma less common in individuals with several tattoos
People with more than one tattoo session may have a decreased risk of the skin…
Browsing: Tumour Stream
New insight into the response mechanism of arsenic in treating acute promyelocytic leukaemia
In this study, researchers conducted a comprehensive characterisation of the tumour microenvironment in APL patients…
Kidney cancer cases are projected to double by 2050
Modifiable risk factors such as obesity, smoking, lack of exercise, diabetes, and hypertension are projected…
NCCN Guidelines Navigator for breast cancer genetic testing and treatment
The National Comprehensive Cancer Network® (NCCN®)—a nonprofit responsible for globally utilised guidelines for cancer care—is sharing…
Could reducing inflammation help combat fatigue in people with early-stage breast cancer?
New research reveals that inflammatory responses may play a role in different types of fatigue…
ASTRO 2025: Pulsed low dose rate chemoradiation therapy can significantly reduce side effects while maintaining treatment effectiveness for patients with oesophageal cancer and non-small cell lung cancer
Researchers have demonstrated that pulsed low dose rate (PLDR) chemoradiation therapy can significantly reduce side effects while…
ASTRO 2025: Patient-reported outcome analysis of NRG Oncology trial in limited-stage small cell lung cancer suggests quality of life benefit with twice – (vs once -) daily radiation
Previously, the primary endpoint results of the NRG-LU005 study assessing the addition of the immunotherapy…
FDA approves imlunestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer
On September 25, 2025, the Food and Drug Administration approved imlunestrant, an oestrogen receptor antagonist,…
ASTRO 2025: Health-related quality of life analysis shows benefit in both proton and photon radiation options in breast cancer patients
Results from the health-related quality of life (HRQOL) analysis of the University of Pennsylvania and…
AI model predicts extranodal extension and outcomes in HPV-positive oropharyngeal cancer
Extranodal extension (ENE) has long been recognised as an adverse prognostic factor in head and…